Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Tradegate  -  02:14:02 2023-03-24 pm EDT
168.93 EUR   +2.41%
03/22US FDA grants accelerated approval for Incyte's skin cancer therapy
RE
03/09German Shares Falter as Hawkish Fears Gather Steam After Powell Testimony
MT
03/09Merck KGaA and Intel Partner on Sustainable Semiconductor Manufacturing in Europe
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : Goldman Sachs gives a Sell rating

02/07/2023 | 03:04am EDT
share with twitter
share with LinkedIn
share with facebook

Keyur Parekh from Goldman Sachs retains his negative opinion on the stock with a Sell rating. The target price has been modified and is now set at EUR 188 compared to EUR 192.


© MarketScreener with dpa-AFX Analyser 2023
All news about MERCK KGAA
03/22US FDA grants accelerated approval for Incyte's skin cancer therapy
RE
03/09German Shares Falter as Hawkish Fears Gather Steam After Powell Testimony
MT
03/09Merck KGaA and Intel Partner on Sustainable Semiconductor Manufacturing in Europe
MT
03/06MERCK KGAA : DZ Bank reiterates its Sell rating
MD
03/06Merck : Equality and Equal Pay Report
PU
03/03MERCK KGAA : Gets a Buy rating from Credit Suisse
MD
03/03MERCK KGAA : Buy rating from Deutsche Bank
MD
03/03Merck : Compensation Report 2022
PU
03/02ADRs End Mostly Higher, Merck KGaA Trades Actively
DJ
03/02Health Care Lags Market Amid Cyclical Bias - Health Care Roundup
DJ
More news
Analyst Recommendations on MERCK KGAA
More recommendations
Financials
Sales 2023 22 612 M 24 629 M 24 629 M
Net income 2023 3 418 M 3 723 M 3 723 M
Net Debt 2023 7 156 M 7 794 M 7 794 M
P/E ratio 2023 21,0x
Yield 2023 1,37%
Capitalization 71 717 M 78 114 M 78 114 M
EV / Sales 2023 3,49x
EV / Sales 2024 3,16x
Nbr of Employees 64 232
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 164,95 €
Average target price 207,53 €
Spread / Average Target 25,8%
EPS Revisions
Managers and Directors
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Laura Matz Chief Science & Technology Officer
Danny Bar-Zohar Head-Development & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
MERCK KGAA-8.82%78 114
KYOWA KIRIN CO. LTD.-6.03%11 664
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD-13.06%4 918
SK BIOPHARMACEUTICALS CO., LTD.-14.56%3 781
BETTA PHARMACEUTICALS CO., LTD.11.10%3 417
YUHAN CORPORATION-11.19%2 828
MarketScreener: Created by Investors for Investors!
100% Free Registration
fermer